UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
January 20, 2005
(Date of report)
CARACO PHARMACEUTICAL LABORATORIES, LTD.
(Exact name of registrant as specified in its charter)
Michigan 0-24676 38-2505723
------------------------------- ------------------------ -------------------------------
(State or other jurisdiction of (Commission file number) (I.R.S. employer identification
incorporation) no.)
1150 Elijah McCoy Drive, Detroit, Michigan 48202
------------------------------------------------
(Address of principal executive offices)
(313) 871-8400
--------------
(Registrant's telephone number, including area code)
Not Applicable
--------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
140.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition and Item 7.01.
Regulation FD Disclosure
On January 20, 2005, registrant announced its unaudited preliminary
results of operations for the year ended December 31, 2004, as set forth in the
press release included as Exhibit 99.1 hereto, which is incorporated herein by
reference.
Item 9.01. Financial Statements and Exhibits
c) Exhibits.
Exhibit No. Description
99.1 Press Release of Caraco Pharmaceutical Laboratories, Ltd., dated January
20, 2005 announcing unaudited preliminary 2004 year-end results of operations.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, registrant
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CARACO PHARMACEUTICAL LABORATORIES, LTD.
Date: January 20, 2005 By: /s/ Jitendra N. Doshi
-----------------------
Jitendra N. Doshi
Chief Executive Officer
Exhibit Index
99.1 99.1 Press Release of Caraco Pharmaceutical Laboratories,
Ltd., dated January 20, 2005 announcing unaudited
preliminary 2004 year-end results of operations.